Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
02/18/2009 | EP2024369A2 Novel process for the preparation of sildenafil citrate |
02/18/2009 | EP2024334A2 Substituted esters as cannabinoid-1 receptor modulators |
02/18/2009 | EP2023920A2 Cannabinoid receptor antagonists/inverse agonists |
02/18/2009 | EP1747201B8 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
02/18/2009 | CN101370784A Polycyclic indazole derivatives that are erk inhibitors |
02/18/2009 | CN101370498A Targeting GLI proteins in human cancer by small molecules |
02/18/2009 | CN101367784A Vinyl cyanide compounds, preparation and application thereof |
02/18/2009 | CN101367764A Novel synthesis process for 5-amino-1-hydroxyethyl pyrazole or the like |
02/18/2009 | CN101367763A Synthesis process of 1-phenyl-3-methyl-5-pyrazolone |
02/18/2009 | CN101367748A Amide derivatives, process for production of the same, and method for application thereof as insecticide |
02/18/2009 | CN100462007C A corrosion inhibiting biocide and its preparation method |
02/17/2009 | US7491831 PPAR active compounds |
02/17/2009 | US7491829 e.g. 5-(1-(2-aminoethyl)-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime; serine/threonine (MAP) kinase inhibitor; antiiproliferative, aniinflammatory agent; neurodegenerative, cardiovascular diseases |
02/17/2009 | US7491741 Diaminopropionic acid derivatives |
02/17/2009 | US7491718 Aminopeptidase inhibitor; vision defects; administering to eye |
02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
02/12/2009 | WO2009020137A1 Aminopyrazole amide derivative |
02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
02/12/2009 | US20090043096 Method of producing aromatic compound |
02/12/2009 | US20090042966 anticarcinogenic agent; (2S)-3-[(5R)-1-Acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]-2-fluoropropan-1-amine for treating cancer |
02/12/2009 | US20090042961 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
02/12/2009 | US20090042864 Pyrazole compounds |
02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
02/12/2009 | US20090042837 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
02/12/2009 | US20090042820 Tubulin Binding Anti Cancer Agents And Prodrugs Thereof |
02/12/2009 | US20090042730 Substituted Arylketones |
02/12/2009 | CA2695437A1 Aminopyrazole amide derivative |
02/12/2009 | CA2693997A1 Viral polymerase inhibitors |
02/11/2009 | CN101365684A Indazole derivatives that inhibit trpv1 receptor |
02/11/2009 | CN101362720A Pyrazole methanol esters compounds, preparation method and application thereof |
02/11/2009 | CN100460480C Organic electroluminescent device |
02/10/2009 | US7488831 pyrazole compound (e.g. 5-hydroxy-3-trifluoromethylpyrazole) is reacted with a sulfur compound (e.g. 2-ethylthiophenol) in the presence of a base and formaldehyde, to produce a 5-hydroxy-4-thiomethylpyrazole |
02/10/2009 | US7488747 Pyrrole and pyrazole DAAO inhibitors |
02/10/2009 | US7488745 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
02/10/2009 | US7488468 Water solubility, reduced toxicity; photodynamic therapy; administering near infrared fluorescent contrast agent , exposing to an excitation light, and detecting near infrared fluorescence from the contrast agent |
02/10/2009 | US7488356 to obtain fast coloration of keratin fibers that is resistant to light and to washing; hair dyes; oxidation base such as 2,3-diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one dihydrochloride; Hexylene glycol; 2-methyl-5-aminophenol as coupler |
02/10/2009 | US7488355 to obtain fast coloration of keratin fibers that is resistant to light and to washing; hair dyes; oxidation base such as 2,3-diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one dihydrochloride; Hexylene glycol; 2-methyl-5-aminophenol as coupler |
02/05/2009 | WO2009018065A2 Novel glucokinase activators and methods of using same |
02/05/2009 | WO2009016221A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives |
02/05/2009 | WO2009016220A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives |
02/05/2009 | WO2009016218A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
02/05/2009 | US20090036688 Process for Production of 5-Alkoxy-4-Hydroxymethylpyrazole Compound |
02/05/2009 | US20090036686 Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates |
02/05/2009 | US20090036510 P-3-(trifluoromethyl)-5-(p-tolyl)pyrazol-1-yl)benzenesulonylaminooxy- compounds; more effective than celecoxib and have fewer gastrointestinal and cardiovascular side effects; 4-(5-p-methyl-phenyl)-3-trifluoromethyl-pyrazol-1-yl)-benzenesulfonic acid intermediate |
02/05/2009 | US20090036509 N-(Ortho-Phenyl)-1-Methyl -3-Trifluoromethlpyrazole-4-Carboxanilides and Their Use as Fungicides |
02/05/2009 | US20090036508 Amino indazole derivatives |
02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
02/05/2009 | US20090036449 Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors |
02/05/2009 | US20090036439 5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one; bacterial cell wall biosynthesis via the Mur enzyme pathway; bactericides; paraciticides; nematocides; antibiotic-resistant diseases; agiculture; veterinary medicine |
02/05/2009 | US20090036438 Five-membered heterocycles useful as serine protease inhibitors |
02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
02/05/2009 | US20090036305 Pyrazolecarboxamides |
02/05/2009 | CA2692767A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives |
02/05/2009 | CA2692696A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives |
02/04/2009 | EP1542976B1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases |
02/04/2009 | EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
02/04/2009 | CN101360730A Fungicide N-cycloalkyl-benzyl-amide derivatives |
02/04/2009 | CN101360707A Thrombopoietin activity modulating compounds and methods |
02/04/2009 | CN101357903A Novel technique for preparing 4-formyl amino antipyrine |
02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
02/03/2009 | US7485730 Pharmaceutical compounds |
02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
02/03/2009 | US7485659 Anticancer compositions, and methods of making and using the same |
02/03/2009 | US7485657 Anti-cytokine heterocyclic compounds |
02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
02/03/2009 | US7485156 Composition for dyeing keratin fibers, comprising at least one diamino-N,N-dihydropyrazolone derivative, at least one coupler and at least one associative polyurethane polymer |
02/03/2009 | CA2384283C Process for preparing 4-trifluoromethylsulphinylpyrazole derivative |
02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
01/29/2009 | WO2009015369A2 Isophthalamide derivatives inhibiting beta-secretase activity |
01/29/2009 | WO2009015000A1 Pyrazole urea derivatives used as kinase inhibitors |
01/29/2009 | WO2009013211A2 New pyrazol derivatives |
01/29/2009 | WO2009013126A1 Substituted indazole derivatives active as kinase inhibitors |
01/29/2009 | WO2009012998A1 Novel microbiocides |
01/29/2009 | WO2009012954A1 Novel estrogen receptor ligands |
01/29/2009 | WO2008059372A3 Crystal form of (3r,5r)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-metyl-benzylcarbamoyl)-2h-pyrazol-3-yl]-3,5-dihydroxy-heptanoic acid sodium salt |
01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
01/29/2009 | WO2007114848A3 Chemical compounds |
01/29/2009 | US20090030211 Process for the Preparation of Fipronil, an Insecticide, and Related Pyrazoles |
01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
01/29/2009 | US20090029050 Arylidenepyrazolone dye, heat-sensitive transfer recording ink sheet and heat-sensitive transfer recording method |
01/29/2009 | CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity |
01/29/2009 | CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
01/29/2009 | CA2693901A1 Substituted indazole derivatives active as kinase inhibitors |
01/29/2009 | CA2693187A1 New pyrazol derivatives |
01/28/2009 | EP2018372A2 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
01/28/2009 | EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
01/28/2009 | EP2018370A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
01/28/2009 | EP2018367A1 Novel microbiocides |
01/28/2009 | EP1915347B1 New 1 , 2 -diaryl pyrazoles useful as analgetic and anti-inflammatory agents |
01/28/2009 | CN101356155A Phenoxy acetic acids as PPAR-delta activators |
01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
01/27/2009 | US7482470 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
01/27/2009 | US7482466 Hydroxamates as therapeutic agents |
01/27/2009 | US7482461 3-(1-methylpiperidin-4-yl)-5-(1-naphthylsulfonyl)-1H-indazole, central nervous system disorder |
01/27/2009 | US7482375 Compounds useful in therapy |
01/27/2009 | US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists |
01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
01/22/2009 | WO2009012312A1 Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |